CLINICAL AND IMMUNOLOGICAL EFFECTS OF CARBOCYSTEINE IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE

by E. G. Shuganov, Zh. M. Salmasi, A. E. Shuganov
Published 2016-02-01

THROMBOPHILIA AND INTENSITY OF THE INTRAVASCULAR MICROCOAGULATION IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE, ATHEROTHROMBOSIS

by E. A. Shelest, A. E. Shuganov, L. I. Patrushev, I. N. Bokarev
Published 2015-09-01

THROMBOPHILIA AND INTENSITY OF THE INTRAVASCULAR MICROCOAGULATION IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE, ATHEROTHROMBOSIS

by E. A. Shelest, A. E. Shuganov, L. I. Patrushev, I. N. Bokarev
Published 2015-09-01

SMOKING’S ROLE IN THE PATHOGENESIS OF BRONCHIAL AND SYSTEMIC INFLAMMATION AT THE INITIAL STAGE COPD

by A. E. Shuganov, N. A. Raspopina, J. M. Salmas, F. N. Paleev, E. G. Shuganov
Published 2017-04-01

CYTOTOXIC LYMPHOCYTES: THE ROLE IN INFLAMMATION IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE EXACERBATION AND REMISSION

by N. A. Raspopina, E. G. Shuganov, F. N. Paleev, Zh. M. Salmasi, A. E. Shuganov
Published 2016-02-01